Daniel Schlieper

Title: The Innovations of Daniel Schlieper

Introduction

Daniel Schlieper is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of vectors for DNA cloning. His work has implications for genetic engineering and molecular biology.

Latest Patents

One of Schlieper's key patents is the "Positive selection vector based on the caps gene, pCAPs vector." This invention provides a vector with a positive selection possibility for cloning a DNA sequence into a host cell transformed with the vector. The vector contains suitable restriction cleavage sites within a selection gene, the functional expression of which is prevented by the insertion of a foreign gene. It is characterized by a modified cap gene as the selection gene, which codes for a CAP protein with modified DNA binding specificity. The expression of this protein is lethal for adenylate-cyclase-positive host cells. Schlieper holds 1 patent related to this innovative technology.

Career Highlights

Daniel Schlieper is associated with Boehringer Mannheim GmbH, a company known for its advancements in biotechnology and pharmaceuticals. His work at the company has allowed him to explore and develop innovative solutions in genetic engineering.

Collaborations

Throughout his career, Schlieper has collaborated with notable colleagues, including Manfred Schmidt and Benno Muller-Hill. These collaborations have contributed to the advancement of research and development in their respective fields.

Conclusion

Daniel Schlieper's contributions to biotechnology through his innovative patent and collaborations highlight his role as a significant inventor in the field. His work continues to influence advancements in genetic engineering and molecular biology.